|
|
|
Volumn 11, Issue 3, 2008, Pages 204-214
|
|
Terameprocol, a novel site-specific transcription inhibitor with anticancer activity
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLIN DEPENDENT KINASE 1;
DOXORUBICIN;
LIGNAN DERIVATIVE;
PACLITAXEL;
SURVIVIN;
TERAMEPROCOL;
TRANSCRIPTION FACTOR SP1;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
VIRUS PROTEIN;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALZHEIMER DISEASE;
ANGIOGENESIS;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
BLADDER CANCER;
BODY MASS;
CANCER PATIENT;
CANCER THERAPY;
CELL CYCLE;
CLINICAL STUDY;
CLINICAL TRIAL;
DISEASE COURSE;
DRUG DOSE ESCALATION;
DRUG EFFICACY;
DRUG FATALITY;
DRUG INHIBITION;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SYNTHESIS;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FISTULA;
GLIOMA;
HEAD AND NECK CARCINOMA;
HEART BLOCK;
HEMATOLOGIC MALIGNANCY;
HERPES SIMPLEX VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFLUENZA VIRUS;
INJECTION SITE PAIN;
METABOLIC ACIDOSIS;
NONHUMAN;
PLANT;
PSORIASIS;
PUBLICATION;
RESPIRATORY FAILURE;
REVIEW;
RHEUMATOID ARTHRITIS;
SIDE EFFECT;
SKIN FISTULA;
SQUAMOUS CELL CARCINOMA;
STRUCTURE ACTIVITY RELATION;
TRACHEA FISTULA;
TUMOR CELL LINE;
UTERINE CERVIX DYSPLASIA;
VIRUS INFECTION;
WART VIRUS;
WEIGHT REDUCTION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
HUMANS;
MOLECULAR STRUCTURE;
NORDIHYDROGUAIARETIC ACID;
TRANS-ACTIVATION (GENETICS);
|
|
EID: 40049106474
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (44)
|
|
References (66)
|
